Загрузка...
Innovation in Regulatory Science Is Meeting Evolution of Clinical Evidence Generation
At the turn of the century, the pharmaceutical industry began a transition toward a focus on oncology, rare diseases, and other areas of high unmet need that required a new, more complex approach to drug development. For many of these disease states and novel approaches to therapy, traditional appro...
Сохранить в:
| Опубликовано в: : | Clin Pharmacol Ther |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6593618/ https://ncbi.nlm.nih.gov/pubmed/30636288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1354 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|